A detailed history of Twinbeech Capital LP transactions in Dexcom Inc stock. As of the latest transaction made, Twinbeech Capital LP holds 62,839 shares of DXCM stock, worth $5.04 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
62,839
Previous 329,682 80.94%
Holding current value
$5.04 Million
Previous $37.4 Million 88.73%
% of portfolio
0.08%
Previous 0.76%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $17.1 Million - $31 Million
-266,843 Reduced 80.94%
62,839 $4.21 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $36.4 Million - $46.3 Million
329,682 New
329,682 $37.4 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $21.3 Million - $34.2 Million
247,715 New
247,715 $23.1 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $5.78 Million - $6.83 Million
55,558 Added 23.7%
289,965 $33.7 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $19.9 Million - $28.8 Million
234,407 New
234,407 $26.5 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $3.81 Million - $5.27 Million
-40,447 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $5.25 Million - $6.59 Million
40,447 New
40,447 $21.7 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $85,039 - $113,326
-1,050 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $89,029 - $109,977
1,050 New
1,050 $377,000
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $827,292 - $1.31 Million
-17,311 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $633,928 - $991,747
17,311 New
17,311 $3.79 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.